Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AIDS Disease Development 1
暂无分享,去创建一个
Jay Rappaport | Jean-François Zagury | J. Zagury | P. Flores-Villanueva | J. Rappaport | S. Caillat-Zucman | H. Hendel | Alberto Burgos-Tiburcio | S. Bertin-Maghit | J. Ruiz-Morales | M. E. Teran | J. Rodríguez-Tafur | Sophie Caillat-Zucman | Pedro O Flores-Villanueva | Houria Hendel | Alberto Burgos-Tiburcio | Sebastien Bertin-Maghit | Jorge A Ruiz-Morales | Maria E Teran | Juan Rodriguez-Tafur | J. Rodriguez-Tafur
[1] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[2] D. Geraghty,et al. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism. , 1992, Human immunology.
[3] Ali A. Al Jabri. HLA and in vitro susceptibility to HIV infection. , 2002, Molecular immunology.
[4] E. Rosenberg,et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] N. Mendes,et al. HLA antigens and resistance to HIV , 1994, Journal of clinical laboratory analysis.
[6] J. Bell,et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.
[7] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[8] M. Llano,et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. McCluskey,et al. Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.
[10] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[11] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Oka,et al. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. , 1997, Journal of immunology.
[13] S O'Brien,et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.
[14] G. Church,et al. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression , 2000, Nature Genetics.
[15] J. Phair,et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.
[16] F. Christiansen,et al. Ancestral haplotypes: conserved population MHC haplotypes. , 1992, Human immunology.
[17] M. Roger. Influence of host genes on HIV‐1 disease progression , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] E. Yunis,et al. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Coligan,et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. , 1999, Journal of immunology.
[20] A. Cambon-Thomsen,et al. HLA ‐A,‐B,‐DR HAPLOTYPE FREQUENCIES IN FRANCE—IMPLICATIONS FOR RECRUITMENT OF POTENTIAL BONE MARROW DONORS , 1995, Transplantation.
[21] S. Beck,et al. Sequence organisation of the class II region of the human MHC , 1999, Immunological reviews.
[22] F. Christiansen,et al. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes , 1992, Immunogenetics.
[23] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[24] R. Vaughan,et al. Towards a molecular phototyping system for allelic variants of MICA, encoded by polymorphisms in exons 2, 3 and 4 of MHC class I chain-related genes. , 1999, Tissue antigens.
[25] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[26] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Maier,et al. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells. , 2000, Human immunology.
[28] I P Keet,et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. , 1994, The Journal of infectious diseases.
[29] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[30] Jerzy K. Kulski,et al. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease , 1999, Immunological reviews.
[31] A. McWhinnie,et al. Sequence-specific oligonucleotide probing for MICB alleles reveals associations with MICA and HLA-B , 2000, Immunogenetics.